Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.130
-0.140 (-6.17%)
At close: Sep 15, 2025, 4:00 PM EDT
2.130
0.00 (0.00%)
After-hours: Sep 15, 2025, 4:00 PM EDT

Mangoceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
0.520.620.730.01-
Revenue Growth (YoY)
-40.47%-15.81%8083.16%--
Cost of Revenue
0.20.240.30-
Gross Profit
0.310.380.430-
Selling, General & Admin
6.875.546.3920.07
Operating Expenses
12.88.628.5520.07
Operating Income
-12.48-8.24-8.12-1.99-0.07
Interest Expense
--0.01--0.01-0
Interest & Investment Income
0.21-0.01--
Other Non Operating Income (Expenses)
-1.8-0.45-1.1--
Pretax Income
-14.2-8.71-9.21-2-0.07
Earnings From Continuing Operations
-14.2-8.71-9.21-2-0.07
Minority Interest in Earnings
00---
Net Income
-14.2-8.71-9.21-2-0.07
Preferred Dividends & Other Adjustments
0.870.87---
Net Income to Common
-15.08-9.58-9.21-2-0.07
Shares Outstanding (Basic)
52111
Shares Outstanding (Diluted)
52111
Shares Change (YoY)
240.49%84.23%49.22%34.98%-
EPS (Basic)
-3.14-4.84-8.58-2.78-
EPS (Diluted)
-3.14-4.84-8.58-2.78-
Free Cash Flow
-5.83-4.86-7-1.39-0.07
Free Cash Flow Per Share
-1.21-2.46-6.52-1.93-0.13
Gross Margin
61.00%61.70%58.99%54.26%-
Operating Margin
-2419.09%-1337.90%-1109.84%-22279.70%-
Profit Margin
-2921.36%-1555.26%-1259.40%-22352.11%-
Free Cash Flow Margin
-1129.13%-789.74%-957.07%-15545.59%-
EBITDA
-10.54-7.51-8.09-1.99-
D&A For EBITDA
1.940.730.020-
EBIT
-12.48-8.24-8.12-1.99-0.07
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q